Skip to content
10-Q

Quarterly Report

SOLESENCE, INC. SLSN

0001999371-25-005991

← back to feed
Filed
May 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 12, 2025 70.1M sh
Cash And Equivalents Q1 2025 · Mar 31, 2025 $1.82M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $1.41M
Current Liabilities Q1 2025 · Mar 31, 2025 $32.88M
Current Liabilities Q1 2025 · Dec 31, 2024 $25.77M
Current Assets Q1 2025 · Mar 31, 2025 $35.9M
Current Assets Q1 2025 · Dec 31, 2024 $29.35M
Total Assets Q1 2025 · Mar 31, 2025 $57.02M
Total Assets Q1 2025 · Dec 31, 2024 $50M
Shares Diluted Q1 2025 · Mar 31, 2024 58.04M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$3.86M
Stockholders Equity Q1 2025 · Mar 31, 2024 $4.95M
Stockholders Equity Q1 2025 · Dec 31, 2023 $1.9M
Eps Diluted Q1 2025 · Mar 31, 2024 $0.02
Eps Basic Q1 2025 · Mar 31, 2024 $0.02
Sga Expense Q1 2025 · Mar 31, 2024 $1.56M
Rd Expense Q1 2025 · Mar 31, 2024 $910K
Net Income Q1 2025 · Mar 31, 2024 $893K
Operating Income Q1 2025 · Mar 31, 2024 $1.11M
Gross Profit Q1 2025 · Mar 31, 2024 $3.58M
Revenue Q1 2025 · Mar 31, 2024 $9.87M